IP Market Updates
February 22, 2016
IN THE NEWS
 Samsung Wins Several Major Design Patents Highlighting Future Foldable Smartphones with Super-Wide Displays
Patently Apple
Last week Samsung was granted several major smartphone design patents from the U.S. Patent and Trademark Office.
 CAFC reaffirms patent exhaustion doctrine cases en banc in Lexmark Int'l v. Impression Products
IPWatchdog.com
The Patent Act grants to patent owners an exclusionary right that allows them to prevent others from making, using, selling, offering for sale or ...
 Surprise! You bought it, but you don't own it
WND.com
The ruling said: “We hold that, when a patentee sells a patented article under otherwise-proper restrictions on resale and reuse communicated to the ...
 Nokia's Patents Might Not Be Worth What You Think
Seeking Alpha
It seems the market had greater expectations that did not ferment. As a result, Nokia's stock has been downgraded by every analyst under the sun.
 The patent pendulum may be poised to swing back
InsideCounsel
In October 2014, reports said that new patent litigations had declined 40 percent year over year. The cause was widely known by practitioners in the ...
 Marvell agrees to pay record-breaking $750M to university to end patent lawsuit
Ars Technica
In what appears to be the second-largest payment ever over technology patents, Marvell Technology has agreed to pay Carnegie Mellon University ...
 Justice Scalia Impacted Life Sciences Patents, Liability
Bloomberg BNA
Justice Scalia wrote some opinions and made some concurring comments impacting greatly patent rights in the life sciences sector.
 Banks Outpace Technology Companies with FinTech Patents
PatentVue by Envision IP
Bloomberg reported last week that there has been increasing overlap in patented technologies between the banking industry and traditional ...
 Sam Asano's Let's Invent: The misconceived hurdles of patents
The Union Leader
In that long period and since the U.S. patent laws were established, there must have been some attempt to apply for a patent or two. All that patents ...
 Calculating an ROI from your patent portfolio?
IPWatchdog.com
Are you looking for a financial model to explain your patent develop and acquisition programs? Can you answer your CEO's, ...
RECENT DEALS
NLS Pharma Acquires A Portfolio of Strategic Patents
Business Wire
PARIS & STANS, Switzerland--(BUSINESS WIRE)--NLS Pharma announces the acquisition of four patents including one linked to an innovative ... (more)
Gemstone Biotherapeutics Licenses Johns Hopkins Technology
Gemstone Biotherapeutics LLC (Gemstone Bio), a Baltimore-based regenerative medicine company, has exclusively licensed new wound-healing technology from Johns Hopkins University. The technology ... (more)
Qualcomm and Lenovo sign patent deal
Chip maker Qualcomm has agreed to a licensing deal with technology company Lenovo in China. The deal relates to 3G and 4G patents and covers mobile phone devices sold by both Lenovo and Motorola ... (more)
BioTime Enters Cross-Licensing Deal with Asterias
Shares of BioTime were up Wednesday after the company said it entered a share transfer agreement with Asterias (AST) as well as a cross-licensing agreement for pluripotent... (more)
Gen9 and SynbiCITE Announce Partnership
CAMBRIDGE, Mass. & LONDON
Gen9, a leader in the development of scalable technologies for synthesizing and assembling DNA, and SynbiCITE, a pioneering Innovation and Knowledge... (more)
Aequus Licenses Canadian Commercialization Rights
VANCOUVER, BRITISH COLUMBIA
Aequus Pharmaceuticals Inc. (TSXVENTURE:AQS)(OTCQB:AQSZF) (“Aequus” or the “Company”) announced today that... (more)
Precise Biometrics Signs License Agreement with Fingerprint Cards
Precise Biometrics(STO:PREC), the leader in fingerprint software, expands the licensing agreement with Fingerprint Cards to include Precise BioMatch™ Embedded for smart cards. The expanded... (more)
Neon Therapeutics Enters License Agreement with Sanquin
CAMBRIDGE, Mass. & AMSTERDAM
Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, today announced... (more)
BioTime and Asterias Sign Transfer Agreement and Cross-License Agreement
FREMONT, Calif. & ALAMEDA, Calif.
Asterias Biotherapeutics, Inc. (NYSEMKT:AST) and BioTime, Inc. (NYSE MKT and TASE:BTX), both clinical-stage regenerative medicine companies... (more)
Abbott Labs acquires large Alere patent portfolio
Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, MA, in a... (more)
Aequus Licenses Canadian Commercialization Rights
VANCOUVER, BRITISH COLUMBIA
Aequus Pharmaceuticals Inc. (TSXVENTURE:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”) announced today... (more)
|
|
|
|
|
|
